- Home
- CBT
CBT
Cabot Corporation
as 04-04-2025 4:00pm EST
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $97.00 | AVG Volume (30 days): | 433.6K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 7.51 | EPS Growth: | -2.37 |
| 52 Week Low/High: | $75.56 - $117.46 | Next Earning Date: | 05-05-2025 |
| Revenue: | $3,991,000,000 | Revenue Growth: | 1.71% |
| Revenue Growth (this year): | 3.28% | Revenue Growth (next year): | 4.05% |
Latest Cabot Corporation News
CBT Breaking Stock News: Dive into CBT Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Cabot Corporation to Announce Second Quarter 2025 Operating Results
Argus Research
5 days ago
CBT: What does Argus have to say about CBT?
Insider Monkey
6 days ago
Is Cabot Corporation (CBT) the Undervalued Chemical Stock to Buy Now?
Argus Research
12 days ago
CBT: Lowering target price to $88.00
Zacks
13 days ago
Do Options Traders Know Something About Cabot (CBT) Stock We Don't?
Simply Wall St.
22 days ago
Cabot (NYSE:CBT) shareholders have earned a 35% CAGR over the last five years
Argus Research
a month ago
CBT: Lowering target price to $85.00
GlobeNewswire
a month ago
Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursday, March 20, 2025
Compare CBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CBT Cabot Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.